Immunohistochemical Analysis of CD30-Positive Lymphoproliferative Disorders for Expression of CD95 and CD95L
- 1 April 2000
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 13 (4) , 446-451
- https://doi.org/10.1038/modpathol.3880076
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Anaplastic Large Cell Lymphoma: A Distinct Molecular Pathologic EntityThe American Journal of Surgical Pathology, 1997
- Distinctive clinicopathologic features associated with regressive primary CD30 positive cutaneous lymphomas: analysis of 6 casesJournal of Cutaneous Pathology, 1997
- Fas ligand and immune evasionNature Medicine, 1996
- A comparison of clinical, morphological and immunohistochemical features of lymphomatoid papulosis and primary cutaneous CD30(Ki‐1)‐positive anaplastic large cell lymphomaJournal of Cutaneous Pathology, 1995
- CD30/Ki-1-positive lymphoproliferative disorders of the skin--clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group.Journal of Clinical Oncology, 1995
- The Fas Death FactorScience, 1995
- Molecular cloning and expression of the fas ligand, a novel member of the tumor necrosis factor familyCell, 1993
- Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T‐cell or null cell phenotypeHistopathology, 1993
- Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders: A proposal for classification and guidelines for management and treatmentJournal of the American Academy of Dermatology, 1993
- Primary cutaneous CD30-positive large cell lymphoma: Definition of a new type of cutaneous lymphoma with a favorable prognosis.A European multicenter study of 47 patientsCancer, 1993